Abbott Laboratories EBITDA 2010-2024 | ABT
Abbott Laboratories annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Abbott Laboratories EBITDA for the quarter ending September 30, 2024 was $2.660B, a 7.65% increase year-over-year.
- Abbott Laboratories EBITDA for the twelve months ending September 30, 2024 was $9.918B, a 7.35% increase year-over-year.
- Abbott Laboratories 2023 annual EBITDA was $9.721B, a 16.41% decline from 2022.
- Abbott Laboratories 2022 annual EBITDA was $11.629B, a 2.79% decline from 2021.
- Abbott Laboratories 2021 annual EBITDA was $11.963B, a 37.76% increase from 2020.
| Abbott Laboratories Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $9,721 |
| 2022 | $11,629 |
| 2021 | $11,963 |
| 2020 | $8,684 |
| 2019 | $7,546 |
| 2018 | $6,960 |
| 2017 | $5,497 |
| 2016 | $4,544 |
| 2015 | $4,339 |
| 2014 | $4,147 |
| 2013 | $3,852 |
| 2012 | $4,142 |
| 2011 | $4,673 |
| 2010 | $8,712 |
| 2009 | $8,325 |
| Abbott Laboratories Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2,660 |
| 2024-06-30 | $2,474 |
| 2024-03-31 | $2,191 |
| 2023-12-31 | $2,593 |
| 2023-09-30 | $2,471 |
| 2023-06-30 | $2,342 |
| 2023-03-31 | $2,315 |
| 2022-12-31 | $2,111 |
| 2022-09-30 | $2,585 |
| 2022-06-30 | $3,198 |
| 2022-03-31 | $3,735 |
| 2021-12-31 | $3,261 |
| 2021-09-30 | $3,393 |
| 2021-06-30 | $2,266 |
| 2021-03-31 | $3,043 |
| 2020-12-31 | $3,298 |
| 2020-09-30 | $2,303 |
| 2020-06-30 | $1,497 |
| 2020-03-31 | $1,586 |
| 2019-12-31 | $2,145 |
| 2019-09-30 | $1,952 |
| 2019-06-30 | $1,957 |
| 2019-03-31 | $1,492 |
| 2018-12-31 | $1,928 |
| 2018-09-30 | $1,808 |
| 2018-06-30 | $1,732 |
| 2018-03-31 | $1,492 |
| 2017-12-31 | $1,566 |
| 2017-09-30 | $1,543 |
| 2017-06-30 | $1,464 |
| 2017-03-31 | $924 |
| 2016-12-31 | $1,273 |
| 2016-09-30 | $1,237 |
| 2016-06-30 | $1,163 |
| 2016-03-31 | $871 |
| 2015-12-31 | $1,181 |
| 2015-09-30 | $1,096 |
| 2015-06-30 | $1,081 |
| 2015-03-31 | $981 |
| 2014-12-31 | $1,224 |
| 2014-09-30 | $1,083 |
| 2014-06-30 | $1,077 |
| 2014-03-31 | $763 |
| 2013-12-31 | $844 |
| 2013-09-30 | $909 |
| 2013-06-30 | $1,063 |
| 2013-03-31 | $1,036 |
| 2012-12-31 | $564 |
| 2012-09-30 | $1,070 |
| 2012-06-30 | $1,256 |
| 2012-03-31 | $1,252 |
| 2011-12-31 | $2,731 |
| 2011-09-30 | $1,433 |
| 2011-06-30 | $2,585 |
| 2011-03-31 | $2,047 |
| 2010-12-31 | $2,540 |
| 2010-09-30 | $1,858 |
| 2010-06-30 | $2,281 |
| 2010-03-31 | $2,033 |
| 2009-12-31 | $2,411 |
| 2009-09-30 | $2,180 |
| 2009-06-30 | $2,209 |
| 2009-03-31 | $1,525 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $206.001B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $149.494B | 33.69 |
| Boston Scientific (BSX) | United States | $133.617B | 38.42 |
| EssilorLuxottica (ESLOY) | France | $111.202B | 0.00 |
| Medtronic (MDT) | Ireland | $110.969B | 16.48 |
| Haleon (HLN) | United Kingdom | $43.728B | 28.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.249B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $38.021B | 19.72 |
| ResMed (RMD) | United States | $36.555B | 30.04 |
| Terumo (TRUMY) | Japan | $30.395B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $25.604B | 19.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.316B | 14.21 |
| Insulet (PODD) | United States | $18.713B | 74.52 |
| Baxter (BAX) | United States | $17.212B | 11.20 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.271B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.104B | 40.65 |
| Bio-Rad Laboratories (BIO) | United States | $9.534B | 32.40 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.207B | 14.42 |
| Haemonetics (HAE) | United States | $4.393B | 21.44 |
| Prestige Consumer Healthcare (PBH) | United States | $4.188B | 20.83 |
| ICU Medical (ICUI) | United States | $4.014B | 38.22 |
| Perrigo (PRGO) | Ireland | $3.894B | 11.46 |
| Envista Holdings (NVST) | United States | $3.836B | 28.58 |
| Agios Pharmaceuticals (AGIO) | United States | $3.387B | 0.00 |
| Neogen (NEOG) | United States | $3.073B | 35.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.867B | 18.39 |
| QuidelOrtho (QDEL) | United States | $2.758B | 17.75 |
| LeMaitre Vascular (LMAT) | United States | $2.406B | 58.46 |
| Green Thumb Industries (GTBIF) | United States | $1.966B | 34.41 |
| AtriCure (ATRC) | United States | $1.763B | 0.00 |
| InMode (INMD) | Israel | $1.640B | 9.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.432B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.350B | 9.64 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.252B | 0.00 |
| Owens & Minor (OMI) | United States | $1.039B | 8.11 |
| CeriBell (CBLL) | United States | $1.031B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.953B | 31.84 |
| Phibro Animal Health (PAHC) | United States | $0.947B | 16.69 |
| Evolus (EOLS) | United States | $0.867B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.864B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 30.33 |
| Omeros (OMER) | United States | $0.658B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.576B | 0.00 |
| Surmodics (SRDX) | United States | $0.565B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.504B | 0.00 |
| Quanterix (QTRX) | United States | $0.473B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.407B | 34.33 |
| Biote (BTMD) | United States | $0.359B | 7.87 |
| Cerus (CERS) | United States | $0.344B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.338B | 32.11 |
| Valneva SE (VALN) | France | $0.329B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 19.00 |
| Zynex (ZYXI) | United States | $0.265B | 55.47 |
| High Tide (HITI) | Canada | $0.262B | 108.67 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.229B | 0.00 |
| MacroGenics (MGNX) | United States | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.28 |
| Sanuwave Health (SNWV) | United States | $0.179B | 2.52 |
| Brainsway (BWAY) | Israel | $0.165B | 98.70 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.50 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.139B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.76 |
| Veru (VERU) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.076B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.074B | 38.17 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Modular Medical (MODD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.95 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |